Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PTAFR | P25105 | 1/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.34 |
| ▸ | CDK1 | P06493 | 2/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.34 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.34 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2515713 | 0.87 | PDK2 (0.43) | PDK2CYP1A2CYP2C19KMT2AHTT | |
| SCHEMBL16276482 | 0.84 | PDK2 (0.42) | PDK2CYP1A2CYP2C19KMT2APTAFR | |
| SCHEMBL80915 | 0.83 | PDK2 (0.41) | PDK2CYP1A2CYP2C19KMT2AABL1 | |
| SCHEMBL17427078 | 0.83 | PDK2 (0.45) | PDK2CYP1A2CYP2C19KMT2AHTT | |
| SCHEMBL16276475 | 0.82 | PDK2 (0.51) | PDK2CYP1A2CYP2C19KMT2AGSK3B | |
| SCHEMBL21226330 | 0.81 | PTAFR (0.40) | PDK2CYP1A2CYP2C19KMT2APTAFR | |
| SCHEMBL80935 | 0.81 | PDK2 (0.39) | PDK2CYP1A2CYP2C19KMT2AABL1 | |
| SCHEMBL17427089 | 0.80 | PDK2 (0.36) | PDK2CYP1A2CYP2C19KMT2ACDC25B | |
| SCHEMBL68937 | 0.79 | PDK2 (0.57) | PDK2CYP1A2CYP2C19KMT2AABL1 | |
| SCHEMBL69252 | 0.79 | PDE4B (0.37) | KMT2AHTTPDE4BFLT4IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3904361-A2 | BORON CONTAINING COMPOUNDS | Merck Patent GmbH (DE) | 2021-11-03 | — | — | EP | disclosed |
| EP-3052505-B1 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH (DE) | 2021-06-23 | — | — | EP | disclosed |
| US-20160248015-A1 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH (DE) | 2016-08-25 | — | — | US | disclosed |
| US-20160248015-A1 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH (DE) | 2016-08-25 | — | — | US | disclosed |
| WO-2015049030-A2 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-04-09 | — | — | WO | disclosed |
| US-8129899-B1 | Azafluorene derivative and organic light-emitting device using the derivative | CANON KABUSHIKI KAISHA (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20120049176-A1 | AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 2012-03-01 | — | — | US | disclosed |
| US-8110685-B2 | Efficient, durable electron transport layers; low driving voltage; simple, low cost production | CANON KABUSHIKI KAISHA (JP) | 2012-02-07 | — | — | US | disclosed |
| US-8034944-B2 | Benzofluoranthene compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20090278118-A1 | BENZOFLUORANTHENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20080154040-A1 | AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160248015-A1 | BORON-CONTAINING COMPOUNDS | BIRC2, BRSK1, CTCF | PDK2 2955/4885CYP1A2 3349/4885CYP2C19 3307/4885 |
| US-20080154040-A1 | AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE | AZI2, CYP1A2, CYP2C19 | PDK2 663/4885CYP1A2 2/4885CYP2C19 3/4885 |
| US-20090278118-A1 | BENZOFLUORANTHENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | XDH, XPO6, PAX3 | PDK2 1300/4885CYP1A2 96/4885CYP2C19 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.